Dr Nischinta Thapa, MD - Medicare Endocrinology in Aberdeen, MD

Dr Nischinta Thapa, MD is a medicare enrolled "Internal Medicine - Endocrinology, Diabetes & Metabolism" physician in Aberdeen, Maryland. She graduated from medical school in 2008 and has 16 years of diverse experience with area of expertise as Endocrinology. She is a member of the group practice Upper Chesapeake Endocrinology Associates, Llc and her current practice location is 650 Mchenry Rd Ste 3300, Aberdeen, Maryland. You can reach out to her office (for appointments etc.) via phone at (443) 843-6100.

Dr Nischinta Thapa is licensed to practice in Maryland (license number D97382) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1215271333.

Contact Information

Dr Nischinta Thapa, MD
650 Mchenry Rd Ste 3300,
Aberdeen, MD 21001-2683
(443) 843-6100
Not Available



Physician's Profile

Full NameDr Nischinta Thapa
GenderFemale
SpecialityEndocrinology
Experience16 Years
Location650 Mchenry Rd Ste 3300, Aberdeen, Maryland
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Nischinta Thapa graduated from medical school in 2008
  NPI Data:
  • NPI Number: 1215271333
  • Provider Enumeration Date: 11/15/2012
  • Last Update Date: 09/15/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 0345514287
  • Enrollment ID: I20231005003179

Medical Identifiers

Medical identifiers for Dr Nischinta Thapa such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1215271333NPI-NPPES
103328040MedicaidPA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RE0101XInternal Medicine - Endocrinology, Diabetes & Metabolism MD461034 (Pennsylvania)Secondary
207RE0101XInternal Medicine - Endocrinology, Diabetes & Metabolism D97382 (Maryland)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Md Harford Memorial HospitalHavre de grace, MDHospital
Umd Upper Chesapeake Medical CenterBel air, MDHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Upper Chesapeake Endocrinology Associates, Llc24665290118

News Archive

Positive results from pivotal trial of SGN-35 in refractory Hodgkin lymphoma presented at ASH 2010

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive results from the pivotal trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate targeted to CD30, a defining marker of Hodgkin lymphoma.

Viewpoints: 'Romney's rebound,' Va. lawmakers' ultrasound vote, Kennedy's not sole interpreters of Senator's legacy

But Mr. Romney also improved his case for his own candidacy, stressing a reform agenda as much as his business biography. In the final days in particular, he pressed his new plan for a 20 percent across-the-board income tax cut, as well as Medicare reform. He stressed his ability to revive the economy, which remains the dominant issue even among conservatives, despite the prominence of social issues in the last week.

Report: Child poverty widespread in America's largest cities

Years after the end of the Great Recession, child poverty remains widespread in America's largest cities. A paper just released by the National Center for Children in Poverty, a research center based at Columbia University's Mailman School of Public Health, reports that nearly three children in five living in Detroit are poor, according to the most recent Census figures. This rate has grown by 10 percentage points since the onset of the Great Recession in 2007.

Vexim granted FDA approval for COHESION bone cement

Vexim specialises in medical instruments and the minimally invasive treatment of vertebral fractures. The company recently announced that it had been awarded FDA certification for its flagship product COHESION™, a bone cement for injection into the vertebra for its fixation following minimally invasive spine repair with the company's SpineJack® device, or following conventional vertebroplasty.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Nischinta Thapa allows following entities to bill medicare on her behalf.
Entity NameUpper Chesapeake Endocrinology Associates, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1366639312
PECOS PAC ID: 2466529011
Enrollment ID: O20080923000613

News Archive

Positive results from pivotal trial of SGN-35 in refractory Hodgkin lymphoma presented at ASH 2010

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive results from the pivotal trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate targeted to CD30, a defining marker of Hodgkin lymphoma.

Viewpoints: 'Romney's rebound,' Va. lawmakers' ultrasound vote, Kennedy's not sole interpreters of Senator's legacy

But Mr. Romney also improved his case for his own candidacy, stressing a reform agenda as much as his business biography. In the final days in particular, he pressed his new plan for a 20 percent across-the-board income tax cut, as well as Medicare reform. He stressed his ability to revive the economy, which remains the dominant issue even among conservatives, despite the prominence of social issues in the last week.

Report: Child poverty widespread in America's largest cities

Years after the end of the Great Recession, child poverty remains widespread in America's largest cities. A paper just released by the National Center for Children in Poverty, a research center based at Columbia University's Mailman School of Public Health, reports that nearly three children in five living in Detroit are poor, according to the most recent Census figures. This rate has grown by 10 percentage points since the onset of the Great Recession in 2007.

Vexim granted FDA approval for COHESION bone cement

Vexim specialises in medical instruments and the minimally invasive treatment of vertebral fractures. The company recently announced that it had been awarded FDA certification for its flagship product COHESION™, a bone cement for injection into the vertebra for its fixation following minimally invasive spine repair with the company's SpineJack® device, or following conventional vertebroplasty.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Nischinta Thapa is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Nischinta Thapa, MD
900 Elkridge Landing Rd Fl 2,
Linthicum, MD 21090-2924

Ph: (443) 462-5010
Dr Nischinta Thapa, MD
650 Mchenry Rd Ste 3300,
Aberdeen, MD 21001-2683

Ph: (443) 843-6100

News Archive

Positive results from pivotal trial of SGN-35 in refractory Hodgkin lymphoma presented at ASH 2010

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive results from the pivotal trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate targeted to CD30, a defining marker of Hodgkin lymphoma.

Viewpoints: 'Romney's rebound,' Va. lawmakers' ultrasound vote, Kennedy's not sole interpreters of Senator's legacy

But Mr. Romney also improved his case for his own candidacy, stressing a reform agenda as much as his business biography. In the final days in particular, he pressed his new plan for a 20 percent across-the-board income tax cut, as well as Medicare reform. He stressed his ability to revive the economy, which remains the dominant issue even among conservatives, despite the prominence of social issues in the last week.

Report: Child poverty widespread in America's largest cities

Years after the end of the Great Recession, child poverty remains widespread in America's largest cities. A paper just released by the National Center for Children in Poverty, a research center based at Columbia University's Mailman School of Public Health, reports that nearly three children in five living in Detroit are poor, according to the most recent Census figures. This rate has grown by 10 percentage points since the onset of the Great Recession in 2007.

Vexim granted FDA approval for COHESION bone cement

Vexim specialises in medical instruments and the minimally invasive treatment of vertebral fractures. The company recently announced that it had been awarded FDA certification for its flagship product COHESION™, a bone cement for injection into the vertebra for its fixation following minimally invasive spine repair with the company's SpineJack® device, or following conventional vertebroplasty.

Read more News

› Verified 5 days ago


Internal Medicine Doctors in Aberdeen, MD

Prashant Rohit Shukla, M.D.
Endocrinology, Diabetes & Metabolism
Medicare: Accepting Medicare Assignments
Practice Location: 998 Hospitality Way, Suite 102, Bayside Internal Medicine, Llc, Aberdeen, MD 21001
Phone: 410-297-9500    Fax: 410-297-9016
John Merren Byrne, D.O.
Endocrinology, Diabetes & Metabolism
Medicare: Not Enrolled in Medicare
Practice Location: 995 Hospitality Way, Aberdeen, MD 21001
Phone: 410-306-7880    
Smita Massey-gomez, M.D.
Endocrinology, Diabetes & Metabolism
Medicare: Accepting Medicare Assignments
Practice Location: 995 Hospitality Way, Aberdeen, MD 21001
Phone: 410-306-7880    
Meaghan Moxley,
Endocrinology, Diabetes & Metabolism
Medicare: Accepting Medicare Assignments
Practice Location: 650 Mchenry Rd Ste 3300, Aberdeen, MD 21001
Phone: 443-843-6100    
Dr. Anuraag Sood, MD
Endocrinology, Diabetes & Metabolism
Medicare: Not Enrolled in Medicare
Practice Location: 19 Walnut Ln, Aberdeen, MD 21001
Phone: 410-272-3233    Fax: 410-273-9465
Dr. Joseph K Llanos, M.D.
Endocrinology, Diabetes & Metabolism
Medicare: Not Enrolled in Medicare
Practice Location: 1429 Viridian Rd, Aberdeen, MD 21001
Phone: 240-205-1694    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.